In vitro activities of new quinolones against Helicobacter pylori

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 12, 1997, Pages 2790-2792

  Carbone, Maria ^a   Fera, Maria Teresa ^a   Cecchetti, Violetta ^b   Tabarrini, Oriana ^b   Losi, Elena ^c   Cusumano, Vitaliano ^a   Teti, Giuseppe ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; NOTE; PRIORITY JOURNAL;

EID: 0030833032     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.12.2790     Document Type: Note

References (28)

1. Banatvala, N., G. R. Davies, Y. Abdi, L. Clements, D. S. Rampton, J. M. Hardie, and R. A. Feldman. 1994. High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 35:1562-1566.
2. Borody, T. J., P. Andrews, G. Fracchia, S. Brandi, N. P. Shortis, and H. Bae. 1995. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 37:477-481.
3. Cecchetti, V., S. Clementi, G. Cruciani, A. Fravolini, P. G. Pagella, A. Savino, and O. Tabarrini. 1995. 6-Aminoquinolones: a new class of quinolone antibacterials? J. Med. Chem. 38:973-982.
4. Cecchetti, V., A. Fravolini, M. C. Lorenzini, O. Tabarrini, P. Terni, and T. Xin. 1996. Studies on 6-aminoquinolones: synthesis and antibacterial evaluation of 6-amino-8-methylquinolones. J. Med. Chem. 39:436-445.
5. Cederbrant, G., G. Kahlmeter, and A. Ljungh. 1992. Proposed mechanisms for metronidazole resistance in Helicobacter pylori. J. Antimicrob. Chemother. 29:115-120.
6. Dixon, M. F. 1991. Helicobacter pylori and peptic ulceration: histopathological aspects. J. Gastroenterol. Hepatol. 6:125-130.
7. Fera, M. T., M. Carbone, and A. Focà. 1993. Activity of cefixime against Helicobacter pylori. Int. J. Antimicrob. Agents 3:105-108.
8. Flores, B. M., C. L. Fennell, K. K. Holmes, and W. E. Stamm. 1985. In vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agents. Antimicrob. Agents Chemother. 28:188-191.
9. Glupczynski, Y., A. Burette, E. de Koster, J. F. Nyst, M. Deltenre, S. Cadranel, L. Bordeaux, and D. de Vos. 1990. Metronidazole resistance in Helicobacter pylori. Lancet 335:976-977.
10. Glupczynski, Y., M. Labbe, A. Burette, M. Delmee, V. Avesani, and C. Bruck. 1987. Treatment failure of ofloxacin in Campylobacter pylori infection. Lancet i:1096.
11. Hirschl, A. M., M. M. Hirschl, and M. L. Rotter. 1993. Comparison of three methods for the determination of the sensitivity of Helicobacter pylori to metronidazole. J. Antimicrob. Chemother. 32:45-49.
12. Knapp, C. C., M. D. Ludwig, and J. A. Washington. 1991. In vitro activity of metronidazole against Helicobacter pylori as determined by agar dilution and agar diffusion. Antimicrob. Agents Chemother. 35:12311-1231.
13. Lacey, S. L., S. F. Moss, and G. W. Taylor. 1993. Metronidazole uptake by sensitive and resistant isolates of Helicobacter pylori. J. Antimicrob. Chemother. 32:393-400.
14. Marshall, B. J., J. A. Armstrong, G. J. Francis, N. T. Nokes, and S. H. Wee. 1987. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis. Digestion 37(Suppl. 2):16-30.
15. Marshall, B. J., C. S. Goodwin, J. R. Warren, R. Murray, E. Blincow, S. J. Blackbourn, M. Phillips, T. E. Waters, and C. R. Sanderson. 1988. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1:1437-1442.
16. Marshall, B. J., and J. R. Warren. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i:1311-1314.
17. McNulty, C. A. M., and J. C. Dent. 1988. Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents. Eur. J. Clin. Microbiol. Infect. Dis. 7:566-569.
18. McNulty, C. A. M., J. C. Dent, G. A. Ford, and S. P. Wilkinson. 1988. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa. J. Antimicrob. Chemother. 22:729-738.
19. McNulty, C. A. M., J. C. Dent, and R. Wise. 1985. Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob. Agents Chemother. 28:837-838.
20. National Committee for Clinical Laboratory Standards. 1980. Standard method for dilution antimicrobial susceptibility tests for bacteria which grow aerobically. Proposed standard PSM-7. National Committee for Clinical Laboratory Standards, Villanova, Pa.
21. Rautelin, H., K. Seppälä, O. V. Renkonen, U. Vainio, and T. U. Kosunen. 1992. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob. Agents Chemother. 36:163-166.
22. Rauws, E. A. J., W. Langenberg, H. J. Houthoof, H. C. Zanen, and G. N. J. Tytgat. 1988. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94:33-40.
23. Rauws, E. A. J., and G. N. J. Tytgat. 1990. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet i:1233-1235.
24. Stone, J. W., R. Wise, I. A. Donovan, and J. Gearty. 1988. Failure of ciprofloxacin to eradicate Campylobacter pylori from the stomach. J. Antimicrob. Chemother. 22:92-93.
25. von Rosenstiel, N., and D. Adam. 1994. Quinolone antibacterials. An update of their pharmacology and therapeutic use. Drugs 47:872-901.
26. Westblom, T. U., B. R. Midkiff, and S. J. Czinn. 1993. In vitro susceptibility of Helicobacter pylori to trospectomycin, pirlimycin (U-57930E), mirincamycin (U-24729A) and N-demethyl clindamycin (U-26767A). Eur. J. Clin. Microbiol. Infect. Dis. 12:560-562.
27. Westblom, T. U., and P. Unge. 1992. Drug resistance of Helicobacter pylori: memorandum from a meeting at the 6th International Workshop on Campylobacter, Helicobacter and Related Organisms. J. Infect. Dis. 165:974-975.
28. Zeiler, H. J., and K. Grohe. 1984. The in vitro and in vivo activity of ciprofloxacin. Eur. J. Clin. Microbiol. 3:339-343.